Divalproex Sodium Tablet, Film Coated, Extended Release
Product Images NDC 70518-4557

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 70518-4557). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (546b07bd 7dba 49c9 8caf 7914600d4d19 01)

Chemical structure diagram depicting the molecular composition of divalproex sodium, showing the sodium salt and acid forms of the compound in a polymeric arrangement.*

FDA Label Image

Image (546b07bd 7dba 49c9 8caf 7914600d4d19 02)

A line graph comparing the percentage reduction in complex partial seizure (CPS) rate between divalproex sodium delayed-release tablets and placebo across a patient population. The y-axis shows percent reduction in CPS rate, indicating improvement or worsening, and the x-axis represents the percentage of patients. Two curves depict patient response distributions for treatment and placebo groups.*

FDA Label Image

Image (546b07bd 7dba 49c9 8caf 7914600d4d19 03)

A cumulative percentage plot illustrating the percent reduction in CPS rate among patients taking divalproex sodium delayed-release tablets. The chart compares high dose and low dose groups, with the y-axis showing percentage change in CPS rate from -100% to 100%, and the x-axis showing percentage of patients from 0 to 100%, indicating improvement or worsening in CPS rates.*

FDA Label Image

Image (546b07bd 7dba 49c9 8caf 7914600d4d19 04)

A bar graph comparing the values for placebo and divalproex sodium extended-release tablets. The vertical axis ranges from 0 to 1.2, with the placebo bar reaching 0.6 and the divalproex sodium bar reaching 1.2, indicated with an asterisk denoting statistical significance (p=0.006).*

FDA Label Image

Remedy_label (Remedy Label)

Label for divalproex sodium extended-release tablets, 250 mg strength, packaged as 30 tablets. The label shows the product name, dosage form, quantity, NDC 70518-4557-00, and identifies the repackager as RemedyRepack Inc., Indiana, PA. Manufacturer is Unichem Labs Ltd., Goa, India. Storage instructions and usual dosage reference noted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.